MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-06-0042251
Rowan Bioceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.31 Cr
▲ 11% YoY
Net profit · FY 2025
₹45.86 Lakh
Net margin 6.3%
EBITDA · FY 2025
₹75.7 Lakh
EBITDA margin 10.4%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹41.5 Lakh
Issued & subscribed
Open charges
₹3.15 Cr
Secured borrowings
Company age
21 yrs
Est. 2005
Employees · EPFO
17
Provident fund records
About Rowan Bioceuticals Private Limited
Data last updated:
Rowan Bioceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 February 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2005PTC132842. Its GSTIN is 07AACCR9630C1ZJ (Delhi).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹41.5 Lakh. It is led by directors Sangeeta Narang and Arun Narang.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 324 3rd Floor Plot No 12 Road No 44 Rani Bagh Pitampura, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.31 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹45.86 Lakh (net margin 6.3%) and EBITDA of ₹75.7 Lakh (EBITDA margin 10.4%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 3% over five years.
The company has about 17 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3.15 Cr on record.
Rowan Bioceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0042251). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rowanbio.in.
Company details
CIN U24232DL2005PTC132842
Registration Number 132842
Incorporation Date 09 February 2005
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-06-0042251
Key People
Sangeeta Narang Director Arun Narang Director Recognitions & Rankings of Rowan Bioceuticals
Contact details
Rowan Bioceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is rowanbio.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address324 3rd Floor Plot No 12 Road No 44 Rani Bagh Pitampura, New Delhi, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rowan Bioceuticals Private Limited, buy the company report.
Comprehensive company report
Rowan Bioceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Rowan Bioceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rowan Bioceuticals Private Limited, buy the company report.
Financials of Rowan Bioceuticals Private Limited
FY 2025 filings availableRowan Bioceuticals Private Limited reported revenue of ₹7.31 Cr (up 11% YoY) for FY 2025.
Revenue · FY 2025
₹7.31 Cr ▲ 11%
Net profit · FY 2025
₹45.86 Lakh margin 6.3%
EBITDA · FY 2025
₹75.7 Lakh margin 10.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 9%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 13%
5 years · compounded
▼ 9%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 11% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹75.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹45.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.4% | ||||
| Net Profit Margin | 6.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rowan Bioceuticals Private Limited, buy the company report.
Board of directors of Rowan Bioceuticals Private Limited
Rowan Bioceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sangeeta Narang | Director | 09 Feb 2005 | 21 Years 8 Months | Current |
| Arun Narang Also directs: Rowan Recherche LLP | Director | 09 Feb 2005 | 21 Years 8 Months | Current |
Peer comparison
Rowan Bioceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ravenmac Pharmaceuticals Private Limited | ₹7.34 Cr (FY 2025) | 17.0% | Amritsar, Punjab, India | |||
| Drbest Pharmaceuticals Private Limited | ₹7.34 Cr (FY 2024) | -6.0% | Chandigarh, India | |||
| Rowan Bioceuticals Private Limitedthis company | ₹7.31 Cr (FY 2025) | ₹45.86 Lakh | 6.3% | 11.0% | 17 | New Delhi, Delhi, India |
| Associated Clinical Aids Private Limited | ₹7.27 Cr (FY 2025) | 19.0% | Kozhikode, Kerala, India | |||
| Speciality Meditech Private Limited | ₹7.27 Cr (FY 2024) | 9.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Rowan Bioceuticals Private Limited, buy the company report.
Auditor
Rowan Bioceuticals Private Limited is audited by JINESH MANOJ & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JINESH MANOJ & CO. | FY 2023 | 014964N |
Shareholding
The shareholding of Rowan Bioceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rowan Bioceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.15 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Oct 2022 | 100621313 | Others | ₹20 Lakh | Open | |
| 11 Mar 2013 | 10409984 | Others | ₹2.95 Cr | Open |
To see the full charge records of Rowan Bioceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Rowan Bioceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rowan Bioceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rowan Bioceuticals Private Limited has a workforce of 17 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
Employee count
17
Active EPFO establishments
1
Employee growth
-5.56%
GST
Rowan Bioceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCR9630C1ZJ | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rowan Bioceuticals Private Limited, buy the company report.
Recent activity
Rowan Bioceuticals Private Limited has 2 board changes on record since 2005: 2 appointments. The latest: Arun Narang was appointed as Director on 09 Feb 2005.
AGM
Rowan Bioceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rowan Bioceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others of Rs. 295.00 Lakh registered on 11 Mar 2013 with Charge ID 10409984 was modified on 30 Jan 2025.
Charges
A charge with Others amounted to Rs. 20.00 Lakh with Charge ID 100621313 was registered on 11 Oct 2022.
Charges
A charge with Others amounted to Rs. 295.00 Lakh with Charge ID 10409984 was registered on 11 Mar 2013.
Appointed
Arun Narang was appointed as Director.
Appointed
Sangeeta Narang was appointed as Director.
Incorporation
09 Feb 2005
Rowan Bioceuticals Private Limited was registered on 09 Feb 2005 with Roc Delhi & aged 21 years 8 months as per MCA records.
Frequently asked questions
Rowan Bioceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 February 2005 (21+ years old) and is registered under CIN U24232DL2005PTC132842.
Rowan Bioceuticals has 2 current directors:
- Sangeeta Narang - Director
- Arun Narang - Director
The latest financial statements of Rowan Bioceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Rowan Bioceuticals is 07AACCR9630C1ZJ, registered in Delhi.
The CIN (Corporate Identification Number) of Rowan Bioceuticals is U24232DL2005PTC132842. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rowan Bioceuticals was incorporated on 09 February 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rowan Bioceuticals by revenue are Ravenmac Pharmaceuticals Private Limited, Drbest Pharmaceuticals Private Limited, Associated Clinical Aids Private Limited, Speciality Meditech Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Arun Narang was appointed as Director on 09 Feb 2005. Sangeeta Narang was appointed as Director on 09 Feb 2005.
Yes, Rowan Bioceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-06-0042251).
Rowan Bioceuticals can be reached through the website rowanbio.in. Its registered office is in New Delhi, Delhi, India.
The registered office of Rowan Bioceuticals is at 324 3rd Floor Plot No 12 Road No 44 Rani Bagh Pitampura, New Delhi, Delhi, India – 110034.